Country: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
Hydrochlorothiazide; Dexamethasone
Vetoquinol Ireland Limited
QC03AX01
Hydrochlorothiazide; Dexamethasone
50, 0.5 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Non food-producing horses
hydrochlorothiazide, combinations
Cardiovascular
Authorised
1989-10-01
Health Products Regulatory Authority 28 August 2019 CRN00987J Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Diurizone Injectable 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCES Hydrochlorothiazide 50 mg Dexamethasone 0.5 mg EXCIPIENT Benzyl Alcohol 0.01 ml For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. A colourless, slightly viscous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle Horses declared as not being intended for slaughter for human consumption. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _Cattle:_ Congestion and oedema of the udder Persistent oedema during lactation Pulmonary congestion and oedema Oedema of surgical wounds Oedema of allergic conditions _Horses:_ Generalised congestion and oedema Oedema of sheath AnasarcaOedema in allergic conditions 4.3 CONTRAINDICATIONS Do not use in pregnant animals. Do not use in animals with viral infections, during the viraemic phase. Do not use in animals with diabetes mellitus, congestive heart failure, chronic nephritis, osteoporosis or glaucoma. Do not use in animals with hepatic encephalopathy. Do not use in cases of severe hypokalemia. Do not use in animals with known hypersensitivity to the active ingredients. Do not use in horses for the treatment of laminitis. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Health Products Regulatory Authority 28 August 2019 CRN00987J Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS For intravenous administration, use a tepid solution and inject slowly. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS None. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) The association of Hydrochlorothiazide and Dexamethasone acetate may induce hepatic encephalopathy. Corticosteroids may delay wound healing and the immunosuppressant actions may weaken resistance to or exacerbate existing infections. In the সম্পূর্ণ নথি পড়ুন